EmboTrap ® II Revascularization Device (Neuravi) in Acute Ischemic Stroke
ConditionAcute Ischemic Stroke
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNiguarda Hospital
About this trial
The primary aim of Registrap study is to assess the safety and effectiveness of the EmboTrap®II Clot Retriever device (Neuravi) in patients with acute ischemic stroke from large vessel occlusion.
Eligibility criteria
Qualifiers
Signed Informed Consent Form
Large Vessel Occlusion on CTA or MRA in the Anterior or Posterior Proximal Cerebral Vasculature up to A1, M1, Dominant M2, P1
ASPECTS ≥ 6
Mismatch or good collaterals showed at MR or multiphasic CTA or pCT
Disqualifiers
Informed consent not given
Extracranial or tandem occlusion
Trial design
Treatments tested in this trial
- Mechanical thrombectomy with EmboTrap ® II Device
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Niguarda Hospital
Lead sponsor
Neuravi Limited
Collaborator
Source ClinicalTrials.gov